Author

E. Mamroud

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 3 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 4 Research Focus:host-pathogen & immune response· 3 Organism:mouse· 3 Assay:behavioral assay· 1 Research Focus:drug response / drug discovery· 1 Organism:rat· 1

Frequent Co-Authors

M. Aftalion· 3 shared Y. Vagima· 3 shared B. Politi· 2 shared D. Gur· 2 shared H. Achdout· 2 shared H. Tamir· 2 shared N. Erez· 2 shared N. Paran· 2 shared

Activity by Year

2020-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersMicrobiology

M. Aftalion

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

An Effective mRNA-LNP Vaccine Against the Lethal Plague Bacterium

E. Kon, Y. Levy, U. Elia, H. Cohen, I. Halevy, M. Aftalion, A. Ezra, E. Bar-Haim, G. S. Naidu, Y. Diesendruck, S. Rotem, N. Ad-El, M. Goldsmith, E. Mamroud, D. Peer, O. Cohen

This study develops an mRNA-LNP vaccine against Yersinia pestis, showing it provides full protection against infection in animals.

bioRxiv · Aug 7, 2022 · PreprintMicrobiology

Phage therapy potentiates second-line antibiotic treatment against pneumonic plague

Y. Vagima, D. Gur, M. Aftalion, S. Moses, Y. Levy, A. Makovitzki, T. Holtzman, Z. Oren, Y. Segula, E. Fatelevich, A. Tidhar, A. Zauberman, S. Rotem, E. Mamroud, I. Steinberger-Levy

This paper shows that combining phage therapy with ceftriaxone improves survival in a mouse model of pneumonic plague caused by multidrug-resistant Yersinia pestis.

bioRxiv · Feb 7, 2022Microbiology

Monitoring group activity of hamsters and mice as a novel tool to evaluate COVID-19 progression, convalescence and rVSV-ΔG-spike vaccination efficacy

S. Melamed, B. Politi, E. Grauer, H. Achdout, M. Aftalion, D. Gur, H. Tamir, Y. Yahalom-Ronen, S. Maimon, E. Yitzhak, S. Weiss, A. Rosner, N. Erez, S. Yitzhaki, S. C. Shapira, , T. Israely

This study uses group activity monitoring in hamsters and mice to assess SARS-CoV-2 infection, convalescence, and vaccine efficacy.

Frontiers in Bioengineering and Biotechnology · Oct 1, 2021Peer-reviewedImmunology

A single dose of recombinant VSV-{triangleup}G-spike vaccine provides protection against SARS-CoV-2 challenge

Y. Yahalom-Ronen, H. Tamir, S. Melamed, B. Politi, O. Shifman, H. Achdout, E. B. Vitner, O. Israeli, E. Milrot, D. Stein, I. Cohen-Gihon, S. Lazar, H. Gutman, I. Glinert, L. Cherry, , T. Israely

This study develops a recombinant VSV-ΔG-spike vaccine that provides single-dose protection against SARS-CoV-2 in hamsters by inducing neutralizing antibodies and preventing lung pathology.

bioRxiv · Jun 18, 2020Microbiology